Literature DB >> 2410169

Acetylcholine receptor antibody characteristics in myasthenia gravis. III. Patients with low anti-AChR antibody levels.

A Vincent, J Newsom-Davis.   

Abstract

Twenty-five myasthenia gravis (MG) patients whose anti-acetylcholine receptor (anti-AChR) titres against denervated human leg AChR fell in the range of less than 0.1-2.0 nM were tested against AChR preparations from normal human leg muscle, and from human extra-ocular muscle, and the results compared with those of sera with titres greater than 2.0 nM. Seven sera failed to react appreciably with any of the AChR. Many of the remaining 18 low titre sera reacted better with normal leg and ocular AChR than with denervated AChR. In contrast, sera from patients with high anti-AChR titres generally reacted better with denervated, AChR, and as a group this was significantly different from the low titre patients. Sera reacting better with ocular AChR are not restricted to patients with purely ocular symptoms. The results indicate a subgroup of myasthenia gravis patients who have low titres, tend to be male and have relatively mild disease. The aetiology of the autoimmune disorder in this subgroup may differ from that in other MG patients.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2410169      PMCID: PMC1577216     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  7 in total

1.  Interaction of human antibody and murine monoclonal antibody with muscle acetylcholine receptor.

Authors:  D S Dwyer; J F Kearney; R J Bradley; G E Kemp; S J Oh
Journal:  Ann N Y Acad Sci       Date:  1981       Impact factor: 5.691

2.  Similarity of acetylcholine receptors of denervated, innervated and embryonic chicken muscles. 2. Subunit compositions.

Authors:  K Sumikawa; E A Barnard; J O Dolly
Journal:  Eur J Biochem       Date:  1982-09-01

3.  Acetylcholine receptor antibody and clinical response to thymectomy in myasthenia gravis.

Authors:  A Vincent; J Newsom-Davis; P Newton; N Beck
Journal:  Neurology       Date:  1983-10       Impact factor: 9.910

4.  Acetylcholine receptor antibody characteristics in myasthenia gravis. I. Patients with generalized myasthenia or disease restricted to ocular muscles.

Authors:  A Vincent; J Newsom-Davis
Journal:  Clin Exp Immunol       Date:  1982-08       Impact factor: 4.330

5.  Antibodies from patients with myasthenia gravis recognize determinants unique to extrajunctional acetylcholine receptors.

Authors:  C B Weinberg; Z W Hall
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

6.  Humoral immunity in myasthenia gravis: biochemical characterization of acquired antireceptor antibodies and clinical correlations.

Authors:  R S Tindall
Journal:  Ann Neurol       Date:  1981-11       Impact factor: 10.422

7.  Acetylcholine receptor antibody characteristics in myasthenia gravis. II. Patients with penicillamine-induced myasthenia or idiopathic myasthenia of recent onset.

Authors:  A Vincent; J Newsom-Davis
Journal:  Clin Exp Immunol       Date:  1982-08       Impact factor: 4.330

  7 in total
  9 in total

1.  The thymus in seronegative myasthenia gravis patients.

Authors:  N Willcox; M Schluep; M A Ritter; J Newsom-Davis
Journal:  J Neurol       Date:  1991-08       Impact factor: 4.849

2.  Repertoires of autoantibodies against homologous eye muscle in ocular and generalized myasthenia gravis differ.

Authors:  C W Zimmermann; F Eblen
Journal:  Clin Investig       Date:  1993-06

3.  Establishment of a human thymic myoid cell line. Phenotypic and functional characteristics.

Authors:  A Wakkach; S Poea; E Chastre; C Gespach; F Lecerf; S De La Porte; S Tzartos; A Coulombe; S Berrih-Aknin
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

4.  Ocular Myasthenia: Clinical Course and the Diagnostic Utility of Assaying Acetylcholine Receptor Antibodies.

Authors:  Raed Behbehani; Abdullah Ali; Ashraf Al-Moosa
Journal:  Neuroophthalmology       Date:  2022-03-15

5.  Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays.

Authors:  A Vincent; J Newsom-Davis
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-12       Impact factor: 10.154

6.  Induction of Anti-agrin Antibodies Causes Myasthenia Gravis in Mice.

Authors:  Min Yan; Ziyang Liu; Erkang Fei; Wenbing Chen; Xinsheng Lai; Bin Luo; Peng Chen; Hongyang Jing; Jin-Xiu Pan; Michael H Rivner; Wen-Cheng Xiong; Lin Mei
Journal:  Neuroscience       Date:  2018-01-13       Impact factor: 3.590

7.  Clinical implementation of anti-acetylcholine receptor antibodies.

Authors:  F E Somnier
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-05       Impact factor: 10.154

8.  Serological Immunoglobulin-Free Light Chain Profile in Myasthenia Gravis Patients.

Authors:  Umberto Basile; Mariapaola Marino; Cecilia Napodano; Krizia Pocino; Paolo Emilio Alboini; Francesca Gulli; Amelia Evoli; Carlo Provenzano; Emanuela Bartoccioni
Journal:  J Immunol Res       Date:  2018-03-25       Impact factor: 4.818

Review 9.  Possible implications of dysregulated nicotinic acetylcholine receptor diffusion and nanocluster formation in myasthenia gravis.

Authors:  Francisco J Barrantes
Journal:  Neural Regen Res       Date:  2021-02       Impact factor: 5.135

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.